ArticleDiscover oncology2026

Establishiment of PANoptosis-related prognostic signature and experimental identification of SIGLEC1 as an oncogenic biomarker in endometrial cancer.

Zhenying Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.